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The incidence of peptic ulcer disease has dramatically decreased in the last recent years, 
mainly due to the knowledge of Helicobacter pylori role in the pathogenesis and the 
eradication treatments. Also, effective acid-decreasing drugs have contributed to the healing 
of most ulcers. As a result, indications for elective surgery have also dramatically decreased. 
However, there are some indications for elective surgery such as refractory ulcers and cases 
of uncertain diagnosis. Also, developing of alternative therapeutic methods such as 
endoscopy or angioembolization has reduced the need for surgery. Endoscopic therapy is 
used in the treatment of bleeding ulcers with high rates of success and in cases of gastric 
outlet obstruction. Angioembolization is used in selected cases of bleeding ulcers. Surgery 
is today indicated when these procedures fail in hemorrhages of peptic origin. Other 
indication for surgery is perforated peptic ulcer, since non-operative treatment cannot be 
considered standard of care. Considerable debate exists concerning the need of adding acid-
decreasing procedures to techniques of bleeding control alone in case of hemorrhage. 
Although the latter are associated with less side effects, the former are associated with lower 
rates of rebleeding. Simple closure of a perforation, however, appears enough if followed by 
Helicobacter pylori eradication and avoidance of NSAIDs. Importantly, any gastric ulcer must 
be biopsied to rule out malignancy, before deciding any conservative treatment. 
INTRODUCTION 
Although the need for surgery has dramatically decreased in the last recent years, some 
indications still persist. Many cases of refractory ulcers or uncertain diagnosis and gastric 
outlet obstruction unsuccessfully treated by endoscopy need elective surgery. Also, cases of 
bleeding ulcers who fail to respond to endoscopic therapy, as well as perforated ulcers, also 
need emergency surgery. 
Controversy exist concerning the need of adding acid-decreasing procedures to simple 
techniques –such as perforation closure or vessel ligation-, and also concerning which 
procedure: resection versus vagotomy. 
Although the incidence of elective surgery for intractable peptic ulcer disease has decreased 
[1] due to the development of acid-suppressive medications and the recognition of the role 
of Helicobacter pylori (Hpy) and NSAIDs on its pathophysiology, the number of urgent 
operations for ulcer complications has remained constant or increased [2]. 
The purpose of this paper is to review the current role of surgery in the treatment of peptic 
ulcer disease including elective and emergency procedures. At this point we will discuss the 
role of minimally invasive techniques. 
Pathophysiologic features of peptic ulcer disease. 
The vast majority of duodenal and gastric ulcers are caused by NSAID intake and/or Hpy 
infection [3]. The pathogenic mechanism is the acid-peptic damage of the gastric or duodenal 
mucosal barrier, so acid secretion suppression with drugs or surgery is the clue to healing 
the ulcer and to decreasing peptic disease recurrence [4].  
Other agents that have been involved in the development of the ulcer disease and its 
recurrence are alcohol, smoking, stress, and other drugs such as aspirin, corticoids or 
cocaine. Some diseases such as Zollinger-Ellison syndrome [5], systemic mastocytosis, 
trauma, burns and major physiological stress [6] are known to cause peptic ulcer too (Table 
1). 
Currently, most patients can be managed in a non-operative way, by avoiding NSAID 
consumption, eradicating Hpy, or by means of endoscopic treatment in case of bleeding [7]. 
However, there are three main clinical scenarios where surgery can still be necessary: drug-
resistant ulcers, uncertain diagnosis and ulcers complicated by bleeding or perforation or, 
less commonly, gastric outlet obstruction. 
ELECTIVE SURGERY 
Drug-resistant ulcer or refractory ulcers 
Nowadays, most peptic ulcers respond to treatment with antisecretory and antimicrobial 
drugs against Hpy infection as well as to the avoidance of NSAID intake, but in some patients, 
the treatment is not effective enough or the peptic disease recurs. Some factors are known 
to influence the healing or recurrence of peptic ulcer disease such as the continued use of 
NSAIDs, gastric hypersecretion states due to a gastrinoma, failed eradication of Hpy or an 
occult focus of carcinoma than mimics ulcer disease. 
Although poorly defined, an ulcer can be considered as refractory if the healing, tested 
endoscopically, is not evident after 8 to 12 weeks of proper medical management - 8 to 12 
weeks of treatment with proton pump inhibitors, Hpy eradication therapy, if necessary, and 
avoidance of NSAIDs [8]. Also ulcers that relapse while on maintenance therapy or after 
multiple courses of treatment can be included in this category. 
The incidence of refractory peptic ulcer disease has decreased in the past five decades. An 
observational study that included 4032 patients suffering from duodenal ulcer between 1976 
and 1993 defined refractory as the persistence of ulceration after 12 weeks of treatment (H2 
receptor antagonist era) by an endoscopic examination. The incidence of refractory duodenal 
ulcer decreased from 33% in 1976-1978 to 7% in 1989-1993 [9]. The study was performed 
before proton pump inhibitors and Hpy treatment became routine, but there are no other 
studies that test their mechanism or their role in the natural history of peptic disease. 
• A. Drugs other than NSAIDs 
o • Acetaminophen 
o • Bisphosphonates 
o • Glucocorticoids 
o • Clopidogrel 
o • Sirolimus 
o • Spironolactone 
o • SSRI: Selective serotonine reuptake inhibitors 
o • Chemotherapy 
o • Cocaine 
• B. Hormonal or mediator-induced, including secondary acid hypersecretory states 
o • Gastrinoma 
o • Systemic mastocytosis 
o • Carcinoid syndrome 
o • Basophilia in myeloproliferative disorders 
o • Antral G cell hyperfunction 
• C. Recurrent ulceration following gastrectomy for peptic ulcer disease 
• D. Infections non H. Pylori) 
o • Herpes simplex virus type I 
o • Cytomegalovirus 
o • Other infections 
• E. Mechanical causes 
o • Duodenal obstruction 
• F. Radiation therapy 
• G. Inflammatory and infiltrating disease 
o • Sarcoidosis 
o • Crohn’s disease 
o • Other 
• H. Idiopathic 
o • Idiopathic hypersecretory duodenal ulcer 
Table 1. Other causes of peptic ulcer disease. 
In refractory or recurrent ulcers persistence of Hpy infection, the continuation of NSAID 
intake, gastrinoma and other uncommon causes (Table 1) have to be ruled out. As a result, 
the first step is to confirm with the patient and relatives a real avoidance of NSAIDs. 
The second step is confirmation of a true absence of Hpy. Evaluation for Hpy presence is 
usually done by culture or biopsy – samples taken by endoscopy [10] -, urea breath testing 
or serology [11], although this has a low accuracy. Although a single positive test is enough 
to diagnose the infection, at least two negative tests are necessary to accept negativity.  
If these factors are excluded, then an endoscopic biopsy must be performed to exclude 
malignancies or other benign disease [12]. If malignancy is suspected, surgery is needed 
irrespective of the biopsy result. (See below) 
Also, a search for gastrinoma must be performed, even in the absence of family history. This 
can be accomplished by means of fasting serum gastrin assessment [13] and the secretin 
stimulation test. Caution must be taken since patients receiving proton pump inhibitors can 
exhibit elevated serum gastrin levels. In this case, the levels must be repeated one week 
after drug withdrawal. The secretin stimulation test can differentiate patients with gastrinoma 
from those having other causes of hypergastrinemia. 
Serum gastrin false negatives are possible. If the clinical suspicion of gastrinoma is high, 
then serum chromogranin A levels must be obtained [14].  
If a biochemical diagnosis of gastrinoma has been made, anatomical location must be 
searched by means of CT, MRI or intraoperative ultrasound, and treated according to 
location. 
After ruling out all the known causes, elective surgery can be indicated.  
Uncertain diagnosis 
In some cases, a gastric - or less commonly, a duodenal ulcer – has atypical features 
suggesting it is not a peptic ulcer. They can be caused by a gastric carcinoma or lymphoma 
and, in the case of the duodenum, by a pancreatic or duodenal carcinoma 12. They must be 
upfront biopsied by endoscopy. The same as refractory ulcers, if malignancy is suspected, 
surgery is needed irrespective of the biopsy result. 
Gastric outlet obstruction 
The obstruction caused by peptic ulcer disease is today the least common indication for 
operation in these patients [15]. It is believed to be the result of edema and scars produced 
by the ulcer, followed by healing and fibrosis, which lead to obstruction of the gastroduodenal 
junction (usually in the first part of the duodenum).  
Nowadays, outlet gastric obstruction due to peptic ulcer disease is exceptional because of 
the improvement of medical care and endoscopic procedures [16]. 
The main symptom is vomiting, which typically occurs postprandial, of undigested food, 
devoid of any bile. A history of previous peptic ulcer disease and loss of weight is also 
common. In advanced cases, dehydration and nutritional deficiencies are very typical. 
Before any kind of treatment, correction of electrolyte disorders and nutritional abnormalities 
is necessary, as well as emptying the stomach with a nasogastric tube. 
A diagnostic endoscopy must be performed to rule out malignancy, taking multiple biopsies 
followed by endoscopic balloon dilatation in order to resolve the obstacle. This procedure is 
successful in most cases (80-90%). However, Lau and colleagues demonstrated a high rate 
of initial endoscopic failure (17%), from negotiating the stenosis, or from balloon induced 
perforation. They also revealed that, even in patients with initial successful dilatation, at least 
one half will require subsequent operation. As a result, they recommend balloon dilatation 
only for high risk patients [17].  
Other authors recommend endoscopic balloon dilatation techniques followed by the 
placement of a stent, but there are no long-term studies comparing these procedures in 
benign disorders [18]. 
Csendes and colleagues compared three operations for obstructing duodenal ulcer: highly 
selective vagotomy (HSV) and gastrojejunostomy, HSV and Jaboulay gastroduodenostomy, 
selective vagotomy (SV) and antrectomy. They found the first and third procedures 
significantly better and they recommend HSV and gastrojejunostomy as the treatment of 
choice for patients with duodenal ulcer and gastric outlet obstruction [19]. 
In summary, the surgical treatment of outlet gastric obstruction due to peptic ulcer disease 
would be indicated if the endoscopic procedures failed. 
Surgical techniques for elective operations 
Elective surgery for peptic ulcer is today uncommon. Understanding the role of Hpy and 
NSAIDs in the physiology of ulcer disease has reduced the number of surgical procedures 
and, in case of refractory or recurrence, the surgical procedures are less invasive and have 
few side effects.  
For duodenal ulcers, the procedures are based on acid secretion reduction. This can be 
accomplished by sectioning the vagus nerve branches (truncal vagotomy, selective 
vagotomy, highly-selective vagotomy) or by reducing gastrin stimulation (antrectomy) or 
decreasing the number of acid-producing parietal cells (subtotal gastrectomy). 
In the case of gastric ulcers, malignancy can be occult, so the ulcer must be excised. As a 
result, gastric resection is advocated (antrectomy or subtotal gastrectomy). 
Vagotomy 
Vagotomy was once commonly performed to treat and prevent peptic ulcer disease. 
However, with the availability of good acid secretion control with H2 receptor antagonists and 
proton pump inhibitors, the need for surgical management of peptic ulcer disease has greatly 
decreased.  
Historically there are three main types of vagotomy techniques: 
Truncal vagotomy (TV) consists of denervation of the main trunk divisions of the vagus; 
therefore, a pyloric drainage procedure, such as pyloromyotomy or pyloroplasty or 
gastrojejunostomy, is needed. This procedure also denervates the liver, biliary tree, 
pancreas, and small and large bowel, so is not free of side effects such as dumping 
syndrome, diarrhea, gastric reflux and a non-negligible ulcer recurrence rate (10%). 
Trying to avoid these side effects, Griffith and Harkins [20] developed selective vagotomy 
which includes the division of the anterior and posterior gastric nerves of Latarjet only (after 
celiac/hepatic branches have been given off). It does not denervate the liver, biliary tree, 
pancreas, or small and large bowel but it does require drainage procedure. Selective 
vagotomy was compared with TV, and they have a similar rate of side effects. 
Highly selective vagotomy, also called parietal cell vagotomy, includes denervation of the 
proximal two thirds of the stomach. This procedure preserves the innervation of the antrum 
and pylorus and the rest of the abdominal viscera; for these it causes minimal side effects is 
considered a safe procedure with a low mortality rate. It decreases acid secretion by 
approximately 65 to 75% which is comparable to TV. The incidence of dumping and diarrhea 
is insignificant, but although this is a safe procedure, it has a higher recurrence rate [21]. 
Today it is only indicated in a few cases, if any [22]. 
Vagotomy is sometimes combined with partial gastrectomy, usually antrectomy, to reduce 
the rate of recurrence.  
Vagotomy and Drainage 
Evacuation of solid components is slowed significantly after TV so a gastric drainage 
procedure must be associated. Gastrojejunostomy or, currently, pyloroplasty are the most 
used procedures. The most common type, Heineke-Mikulicz pyloroplasty, is performed by 
dividing the sphincter longitudinally and closing it transversely. Other techniques are the 
Finney and Jaboulay pyloroplasties, which basically consist of gastro-duodenostomies. All of 
these can be performed safely but they have a 10% recurrence rate and side effects 
(dumping syndrome, diarrhea..) in 10%. If an incomplete vagotomy is performed, then a 
marginal ulceration can appear. 
This technique is currently indicated in emergencies (perforation, bleeding) requiring surgery 
[22] but uncommonly in elective surgery. 
Vagotomy and antrectomy 
As mentioned above, the addition of partial gastrectomy decreases the rate of ulcer 
recurrence (6-7, 9%) [23] since by removing the antrum, the number of gastrin-producing 
cells - as well as some acid-producing parietal cells - is reduced. This technique adds more 
morbidity and mortality rates, and it is more difficult to perform. The gastric remnant should 
not be too large because of the risk of marginal ulceration. 
All of above described procedures, with similar results to open approach, can be safely 
performed through a laparoscopic approach, with some technical modifications.  
To avoid TV, the Taylor procedure combines a section of the posterior vagus branch with 
anterior serosal myotomy [24]. In the Gómez-Ferrer technique, the posterior truncal 
vagotomy is combined with an anterior linear gastrectomy with a stapler [25]. Both 
procedures proved to be efficient in recurrence prevention and in providing satisfactory 
functional patient status. In case of stenosis, bilateral truncal vagotomy with stapled 
gastrojejunostomy can also be performed by laparoscopy [26]. 
Gastric Resection 
In some cases, vagotomy is not sufficient and partial gastrectomy (e.g., antrectomy, subtotal 
gastrectomy) is necessary. The fundaments in ulcer treatment are removal of the portion of 
the stomach containing the ulcer, the gastrin-producing cells that stimulate acid secretion, 
and most of the acid-producing parietal cells. Gastrectomies, however, are seldom indicated 
today in the treatment of peptic ulcer disease unless suspicion of malignancy exists. 
Technical aspects of gastrectomies are beyond the scope of this paper and can be found 
elsewhere [27]. 
Reconstruction is performed with gastroduodenostomy (Billroth I), gastrojejunostomy 
(Billroth II) or by means of a Roux-en-Y technique. 
These techniques can also be performed by laparoscopy, since experience treating gastric 
cancer has shown its feasibility and, by comparison with open surgery, shorter in-hospital 
stays with similar morbidity and mortality rates [28]. 
The need of Hpy eradication - if present - after acid reducing surgery remains controversial, 
since ulcer recurrences can result from incomplete vagotomy or continuation on NSAID 
treatment [29]. The association of postoperative Hpy persistence with premalignant lesions 
[30] and the possibility of influencing ulcer recurrence make eradication advisable. 
Choice of techniques for refractory ulcers: 
Duodenal ulcer: highly-selective anterior vagotomy combined with posterior truncal 
vagotomy, or seromyotomy combined with TV offer the best combination of acid reduction 
and preservation of pyloric function. If some degree of stenosis is present, any type of 
pyloroplasty must be added [31]. 
Gastric ulcer: The treatment can differ according to the Johnson classification of gastric 
ulcers [32] : 
• Type I (in the lesser curvature, associated with decreased acid secretion): distal 
gastrectomy provides a low recurrence rate (0-5%) [31]. Also, good results have been 
reported with HSV [33]. 
• Type II (gastric ulcer synchronous with scarring or ulceration in duodenum or pyloric 
channel): since these ulcers are associated with increased acid secretion, antrectomy with 
vagotomy is the preferred option. 
• Type III (prepyloric ulcer): also associated with increased acid secretion; antrectomy and 
vagotomy are recommended. Outcomes after highly selective vagotomy have not, 
however, been as good as in other gastric ulcer types [34]. 
• Type IV (located high in the lesser curvature, associated with decreased acid secretion): 
subtotal gastrectomy is the procedure of choice. 
MANAGEMENT OF COMPLICATIONS OF PEPTIC ULCER DISEASE 
In general, urgent surgery is required in patients with uncontrolled hemorrhage and 
perforated ulcer with continuous leakage. The election of the technique depends on the ulcer 
location, the type of complication and the overall status of the patient. 
Bleeding ulcer  
Thirty percent of upper gastrointestinal hemorrhages are due to peptic ulcer disease, so 
peptic ulcer bleeding is a common condition. Also, it results in high morbidity and medical 
care cost.  
Most patients can be managed with medical therapy including fluid and blood resuscitation, 
acid suppression and endoscopic techniques. 
Early treatment with intravenous proton pump inhibitors has been shown to reduce 
rebleeding rates [35]. After endoscopic procedures it decreases the rate of active bleeding 
and the need of a new endoscopy. The avoidance of NSAIDs and smoking also helps 
decrease the rate of rebleeding. 
Endoscopic treatment decreases rebleeding rates, the need of operation and reduces the 
mortality rate of the patients with bleeding peptic ulcers. The most effective and less risky 
endoscopic procedures are thermal contact coagulation and injection of epinephrine. They 
are initially successful in 75 to 90% of patients. The rebleeding rate is 10 to 30%, most of 
these episodes occurring within 96 hours. Some factors predict failure of endoscopic therapy 
[36], such as hypotension and ulcers larger than 2 cm. 
Surgery for peptic ulcer hemorrhage is indicated in the following cases: 
• (a) Failure of endoscopic techniques to control the hemorrhage 
• (b) Hemodynamic instability despite strong resuscitation with uncontrolled bleeding 
• (c) Recurrent hemorrhage after a second attempt at endoscopy: the second attempt has a 
reasonable chance of success and lower risk than surgery. However, if two attempts have 
failed, additional attempts are unlikely to be successful. 
Other indications for early surgery include slow bleeding with transfusion requirements 
exceeding three units per day, rare blood types, refusal of transfusion, giant ulcers or co-
morbid disease. 
Angiography can be used in some cases [37]. Embolization of the bleeding vessel has been 
used in the treatment of patients with prohibitive risk at operation, rebleeding after operation 
and with uncertain endoscopic diagnosis. Walsh and colleagues published a series of 50 
consecutive cases at the Cleveland Clinic. Angiography was successful in 52% of patients. 
In 17 cases, patients underwent operation as an attempt to control the bleeding [38]. 
Poultsides in his retrospective study, concluded that the failure of angioembolization can be 
predicted if it is performed late, following blood transfusion of more than 6 units, or for 
rebleeding from a previously suture-ligated duodenal ulcer [39]. 
When non-surgical therapy fails the surgeon should decide two main questions: when to 
operate and which operation to perform. 
Surgical options for the bleeding peptic ulcer are three: oversewing alone or ligation of the 
bleeding point, oversewing /ligation with definitive non-resective ulcer operation - HSV or TV 
plus drainage - or gastric resection. 
Bleeding Duodenal Ulcer 
The number of operations for bleeding duodenal ulcer has decreased considerably due to 
effective endoscopic therapy and medication. Nowadays, between 5 and 10% of patients 
require operation. The most common techniques are vagotomy with drainage combined with 
oversewing of the ulcer, or vagotomy and antrectomy. 
Millat and colleagues, and Hunt and McIntyre [40] compare patients undergoing operation 
for bleeding duodenal ulcer. In summary, they found no difference in mortality but the rates 
of rebleeding were lower in the resected groups than in the groups treated only with 
oversewing, even with associated vagotomy 37. It seems, however, that in those non-
resective operations, if secure oversewing or ligation of the vessel is performed and proton 
pump inhibitors are added postoperatively, the risk of rebleeding is quite low. As a result, the 
current trend is to perform oversewing alone with Hpy eradication treatment and/or long-term 
proton pump inhibitors [37] [41]. 
In cases of patients with shock, in order to reduce operative time and mortality, non-resective 
procedures are recommended, performing only ligation/suture of the bleeding vessel. 
When the bleeding control is very difficult, ligation of the gastroduodenal artery can be 
necessary.  
Bleeding Gastric Ulcer 
The behavior of the bleeding gastric ulcer is different; smaller submucosal vessels are 
involved, bleeding can stop spontaneously and in most cases the size of the bleeding vessels 
is less than 1 mm which explains why endoscopic therapy is effective in approximately 80% 
of cases. 
A bleeding gastric ulcer is best treated by ulcer excision and repairing of the resulting defect 
[41]. The excision extent can vary from a wedge excision in the greater curvature to a partial 
gastrectomy if the ulcer is located at the lesser curvature. In the ulcers located near the 
gastroesophageal junction, biopsy and oversewing can be enough. 
Distal gastric resection to include the bleeding ulcer has been associated with the lowest 
rebleeding rates [37]. A TV can be added if the patient is stable. Vagotomy and drainage with 
oversewing and biopsy or minor resection of the ulcer, followed by long-term acid 
suppression is a reasonable alternative to major operation [42].  
Perforated ulcer 
Perforation of a peptic ulcer is one of the most severe events since it is associated with 
considerable morbidity and mortality [43]. Less than one-third of patients have antecedents 
of peptic ulcer disease before perforation [44]. 
Duodenal 
The perforation takes place in 5-10% of patients with chronic peptic ulcer disease. It is more 
common in men aged between 40 and 60 years. Upon diagnosis, prompt surgery must be 
performed, since this is currently the standard of care [41]. 
Surgical treatment can be limited to closure of the perforation, or a definitive treatment of 
ulcer disease can be performed. Simple closure is the treatment of choice in the management 
of perforated duodenal ulcers [41]. The main perforation closure techniques are simple 
suture, epiploplasty with omental pedicle flap epiploplasty or free omental plug –Graham 
patch- without suture of perforation edges and perforation suture covered by epiploplasty 
[45] [46]. 
Two randomized trials found that simple closure followed by Hpy treatment reduced 
recurrence rates of duodenal, prepyloric, and pyloric ulcers from 30-38% to 4.8-6.1% [47] 
[48]. Our group found in a prospective study with 92 patients having had perforated peptic 
ulcer, that simple closure followed by Hpy eradication is associated with a low rate of 
recurrence and no re-perforation in case of duodenal, pyloric, or pre-pyloric perforated ulcers, 
although this is not acceptable for perforated gastric ulcers [49]. Other studies found similar 
results [50] [51]. Importantly, successful postoperative eradication must be checked. 
Simple closure can be performed laparoscopically by most surgeons, if properly trained. The 
procedure is usually performed with mortality or morbidity rates similar to or even lower than 
through an open approach [52] [53]. However, current evidence does not clearly support 
superiority of laparoscopy over the open approach [54]. Indeed, there are several factor 
associated with poor outcomes of the laparoscopic approach – shock, delayed presentation, 
advanced age, ASA III-IV – which, if present, should guide towards laparotomy [46]. 
On the other hand, definitive treatment (partial gastrectomy or vagotomy) is associated with 
diarrhea, disturbing in some cases. Trying to avoid this adverse effect, highly selected 
vagotomy techniques were developed, but the technical difficulties of these methods make 
them hard to apply in cases of emergency.  
Although conclusive evidence is lacking, if continuation of NSAIDs is predictable - e.g. in 
case of chronic arthritis -, a surgical procedure to decrease acid secretion may be necessary.  
Conservative treatment of the duodenal perforation has been described in the literature 
(Taylor’s method). It consists of measures such as nasogastric aspiration, proton pump 
inhibitors or other acid-suppressives, antibiotics and close monitoring. A few patients could 
benefit from this conservative treatment: those patients who are fasting at the perforation 
moment, with abdominal pain for less than 24 hours, and those showing clinical improvement 
with this approach (decrease of the pain and no other clinical abnormalities). However, this 
method has a high rate of failure (16-28%), morbidity and a non- negligible mortality (5-8%). 
A randomized trial from 1989 [55] compared conservative treatment with surgical perforation 
repair and found a 28% failure rate in the conservative approach. Yet the mortality rate was 
5% in both groups with a non-significant difference in morbidity. The worst outcomes were 
for patients over 70 years. Two perforations were due to carcinoma.  
A more recent paper [56] prospectively studied conservative management with surgery only 
in case of failure of improvement after 24 hours. It was found that more than 50% of patients 
responded to conservative treatment and that the association of some criteria (size of 
pneumoperitoneum larger than the size of the first lumbar vertebra, heart beat over 94 bpm, 
pain at digital rectal exam and age) made emergency surgery necessary. 
Percutaneous drainage associated to conservative treatment has also been reported [57]. 
The difficulty to select patients who will improve without surgery and the possibility that the 
perforation is not from a peptic ulcer make, in most cases, early surgical intervention 
necessary. 
Gastric ulcer 
Patients having a perforated gastric ulcer are usually older and tend to have associated 
diseases leading to a poorer prognosis. As a result, overall mortality rate ranges from 10-
40% [57] [58]. Since the risk of occult malignancy is always present, the theoretical procedure 
of choice is a partial gastrectomy, including the ulcer. However, the usual scenario is the 
case of a patient in shock, dehydrated or with a poor general condition due to co-morbidity. 
In these cases, biopsy of the ulcer margins and simple closure is an acceptable procedure 
[45]. This approach is, nevertheless, associated with high recurrence rates, even with 
reperforation [49]. After recovery, proper study to rule out any occult carcinoma must be 
performed. A recent paper reported non-operative treatment of gastric ulcer, which was 
successful in 78% [60]. In the group for emergency surgery due to unsuccessful conservative 
treatment plus the patients primarily operated on, gastric-preserving surgery –simple closure 
or minor resections- had no different complication rate or hospital stay compared with major 
gastric resection. Concerning long-term outcomes of patients not treated by gastrectomy, 4% 
had ulcer recurrence after a mean follow-up of 36 months [60]. In this paper, the Japanese 
guidelines regarding patient selection for conservative treatment for PGU are reported: within 
24 h of onset; stable condition without severe comorbidities; signs of peritoneal irritation 
localized within the upper abdomen; and small amount of ascites. 
In the cases where the perforation clearly is located in a tumoral area, the options are 
emergency gastrectomy –doubtfully oncologic- or simple closure and to perform oncologic 
gastrectomy at a later stage [45]. 
CONCLUSION 
In summary, to choose the best operation for peptic ulcer disease it is necessary to consider 
the features and the clinical status of the patient, the surgeon´s experience and the published 
evidence [61]. The main recommendations are summarized in Table 2.  
Refractory ulcer* 
    Duodenal  Highly-selective anterior vagotomy combined with posterior truncal vagotomy or seromyotomy combined with posterior truncal vagotomy 
    Gastric  
Type I: Distal gastrectomy 
Type II: Antrectomy with vagotomy 
Type III: Antrectomy with vagotomy 
Type IV: Subtotal gastrectomy 
Uncertain 
diagnosis*  The same than in case of refractory ulcer 
Gastric outlet 
obstruction*  Highly-selective vagotomy with gastrojejunostomy (if balloon dilatation fails) 
Bleeding duodenal 
ulcer  
Partial gastrectomy (less rebleeding rate) 
Suture oversewing (less long-term side effects) 
Bleeding gastric 
ulcer  Ulcer excision (variable from wedge excision to partial gastrectomy) 
Perforated 
duodenal ulcer  
Simple closure 




Biopsy and simple closure in case of patient poor condition 
Table 2. Indications for surgery and recommended techniques. *After excluding diseases other than peptic 
ulcer 
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